Sanjay Rajagopalan, MD
Showing of 9 results
Sanjay Rajagopalan, MD, Leads Clinical Trial Showing Mechanism of Benefit of Mineralocorticoid Receptor Antagonist for Patients with Type 2 Diabetes and Chronic Kidney Disease
Innovations in Cardiovascular Medicine & Surgery | Fall 2024
UH Harrington Heart Vascular Institute’s Chief of Cardiovascular Medicine Co-Authors Three Major Publications on Environmental Impacts in Cardiovascular Health
Recent publications lay out a roadmap and call to action - Innovations of Cardiovascular Medicine & Surgery | Winter 2024
Groundbreaking Review of Air Pollution’s Effect on Cardiometabolic Risk Published in Lancet Diabetes Endocrinology
Innovations in Cardiovascular Medicine & Surgery | February 2024
Exploring the Effects of Policy and Environmental Factors on Health Outcomes
Sanjay Rajagopalan, MD discusses how historical government policies impact health outcomes more than 90 years later and the need to understand external and internal environments to transform the delivery of healthcare.
CINEMA Extends Strategies to Advance Clinical Care of Diabetic Patients
UH Research & Education Update | July 2020
University Hospitals Cardiologists Reimagine Care Delivery in the Era of Coronavirus
Early learnings from COVID-19 - Innovations in Cardiovascular Medicine & Surgery | Summer 2020
What Do a Gila Monster and an Apple Tree Have to Do with Heart Disease?
New Multidisciplinary Center at UH is aggressive in using new drugs to prevent cardiovascular complications of diabetes - Innovations in Cardiovascular Medicine & Surgery | Fall 2019
New Cholesterol Guidelines Endorse the Value of Coronary Artery Calcium Scoring
UH was early adopter of the simple but accurate test, has offered it at no cost since 2016 - Innovations in Cardiovascular Medicine & Surgery - Winter 2019